Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.

Wei LiuWei LiuHesong ZouLianting ChenWenyang HuangRui LvYan XuHuimin LiuYin ShiKefei WangYi WangWenjie XiongShuhui DengShuhua YiWeiwei SuiGuangxin PengYueshen MaHuijun WangLulu LvJian-Xiang WangJun WeiLugui QiuWenting ZhengDehui Zou

Published in: Journal for immunotherapy of cancer (2024)

ChiCTR1900025419 and NCT04690192.

Keyphrases

diffuse large b cell lymphoma
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
mesenchymal stem cells
bone marrow